# AnticoagEvaluator

> Medical app for antithrombotic therapy decisions in non-valvular AF patients. (iPhone/iPad app by American College of Cardiology.)

- Source: https://appshunter.io/ios/app/anticoagevaluator/id609795286 (this page in markdown: same URL + `.md`)
- Developer: [American College of Cardiology](https://appshunter.io/developer/502174543)
- Category: Medical, Reference
- Price: Free
- Rating: 2.30/5 from 3 App Store ratings · 10 written reviews indexed
- Age rating: 17+
- Requires: iOS 11.0 · 25 MB
- Languages: American English
- Released: 2013-03-06
- Data updated: 2026-06-03
- Monetization: free
- User reviews in markdown: https://appshunter.io/ios/app/anticoagevaluator/id609795286/reviews.md

## What is AnticoagEvaluator?

Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to: 
•	Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
•	Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
•	Generate individualized risk for antithrombotic therapy options based on individual clinical trials.
•	Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com

## Key features

- Calculate renal function and stroke/bleed risk
- Review ACC/AHA/HRS guideline therapy
- Generate individualized antithrombotic risk
- Optimize DOAC dosages
- Based on SPARC Tool

## Recent user reviews (10 of 10)

All indexed reviews: https://appshunter.io/ios/app/anticoagevaluator/id609795286/reviews.md

### 1/5 — Useless now.

*2024-08-05*

Since updating to new risk models… the app doesn’t display and actual CHADs-Vasc Score. I understanding what you are going for, but this honestly makes the app less useful and no longer my go-to. Such a shame. Used it for many years and loved it prior to this change.

### 1/5 — Credible?

*2016-01-29*

Results seem very one-sided. Wonder where funding came from? If results always show same anticoag, why have app?

### 5/5 — Great app very useful

*2014-12-14*

The ACC web team is so responsive!!!  App works great now on iPhone 6

### 1/5 — Loss of function in iOS 8

*2014-11-18*

Can no longer select and receive details for a particular therapy option. This needs to be fixed.

### 1/5 — Temporary Workaround

*2014-10-21*

It's become less functional since the IOS 8; you can no longer choose a therapy and see the details of its usefulness or the lack thereof. However, here is temporary workaround until they fix it: after selecting the risk factors for your patient, you click on the email icon and it will give you the relative risk reductions for all of the therapies. 
I know it's inelegant but is still functional. 
Hopefully, they will fix it soon.

### 1/5 — No conversion

*2014-10-07*

Since iOS8 update app is useless as I'm finding with a lot of apps post iOS8.

### 2/5 — Current version fails

*2014-09-23*

Ios8 version does not work

### 4/5 — Top of the screen

*2014-08-07*

Agree with the first review 
Top email and risk summary are hidden behind battery and time

### 2/5 — Ios7 update messed up the app

*2014-07-18*

The new update that made this app ios7 compatible actually has a bug. The bar that is supposed to seperate the app display screen from top part of the screen where time and battery are displayed is actually at the bottom of the screen. Therefore all the results hide behind time and battery icon

### 5/5 — Great tool to estimate risk

*2013-08-07*

Especially like how each therapy can be compared.

## Frequently asked questions about AnticoagEvaluator

### What is AnticoagEvaluator used for?

AnticoagEvaluator is a medical tool designed to help healthcare professionals make informed decisions about antithrombotic therapy for patients with non-valvular atrial fibrillation. It aids in calculating patient risks and reviewing guideline-driven treatment options.

### What kind of risks does AnticoagEvaluator assess?

The app calculates a patient's renal function and assesses their risk of ischemic stroke, thromboembolism, and bleeding. This information is crucial for tailoring antithrombotic therapy.

### Does AnticoagEvaluator provide treatment guidance?

Yes, it reviews ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention. It also generates individualized risk assessments for different antithrombotic therapy options based on clinical trials.

### How does AnticoagEvaluator help with DOACs?

The app improves the accurate use of Direct Oral Anticoagulants (DOACs) by providing adjusted dosages. These dosages are fine-tuned for renal and other patient characteristics, based on prescribing information.

### What is the basis for AnticoagEvaluator?

AnticoagEvaluator is based on the SPARC Tool, which was developed by Peter Loewen, ACPR, Pharm.D., FCSHP. The SPARC Tool can be accessed online at www.sparctool.com.

### What is the user rating for AnticoagEvaluator?

AnticoagEvaluator has a user rating of 2.3 stars from 3 ratings. This indicates a mixed to negative reception from its current user base.

### On which devices can AnticoagEvaluator be used?

AnticoagEvaluator is available for iPhone, iPad, and iPod devices. It is designed for use on Apple's iOS platform.

### How often is AnticoagEvaluator updated?

The latest version of AnticoagEvaluator is 5.0.0.7, which was last updated on November 21, 2024. This suggests a recent update and ongoing maintenance by the developer.

## Version history (last 5 releases)

### 5.0.0.7 — 2024-11-21

This app has been updated with an enhanced Risk Bar which showcases CHA2DS2-VASc and ATRIA stroke risk point scores for all patients alongside the stroke risk magnitude percentage. In addition, a visual display bug was fixed and standard notification functionality was incorporated.

### 4.3 — 2024-07-12

This app has been updated in accordance with the 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation to incorporate additional stroke risk models (ATRIA, GARFIELD), a mortality risk model (GARFIELD), and updates to the existing stroke and bleed risk calculations. This update also includes updated therapy guidance and renal-adjusted therapy dosing information.

### 4.1 — 2023-12-15

Bug fixes

### 4.0 — 2023-09-08

This update includes underlying architecture improvements and minor reference link updates.

### 3.0 — 2019-01-30

This version includes the following:
1)  2019 AFib Guideline Update content
2)  Design updates

## Apps similar to AnticoagEvaluator

| App | Rating | Price | Category |
| --- | --- | --- | --- |
| [Cardiology Clinical Questions.](https://appshunter.io/ios/app/cardiology-clinical-questions/id1278770497) | — | Free | Medical |
| [Mayo Clinic Cardiovascular CME](https://appshunter.io/ios/app/mayo-clinic-cardiovascular-cme/id1578924841) | 3.9 (10) | Free | Medical |
| [CCU Guide](https://appshunter.io/ios/app/ccu-guide/id1293643054) | 4.4 (13) | Free | Medical |
| [PCI App](https://appshunter.io/ios/app/pci-app/id1607148631) | 5.0 (5) | Free | Medical |
| [MAQI2 Anticoagulation Toolkit](https://appshunter.io/ios/app/maqi2-anticoagulation-toolkit/id982592350) | 4.8 (8) | Free | Medical |
| [EHRA Key Messages](https://appshunter.io/ios/app/ehra-key-messages/id904950207) | 4.7 (28) | Free | Medical |

## More apps by American College of Cardiology

- [ACC Connect](https://appshunter.io/ios/app/acc-connect/id542901001)
- [CardioSmart Heart Explorer](https://appshunter.io/ios/app/cardiosmart-heart-explorer/id602929990)
- [CVD Risk Estimator Plus](https://appshunter.io/ios/app/cvd-risk-estimator-plus/id808875968)
- [ACC Advocacy Action](https://appshunter.io/ios/app/acc-advocacy-action/id905043425)
- [ACC Guideline Clinical App](https://appshunter.io/ios/app/acc-guideline-clinical-app/id931723742)

All apps by American College of Cardiology: https://appshunter.io/developer/502174543

## Related topics

[the noac](https://appshunter.io/ios/topics/the-noac) · [aormfrest](https://appshunter.io/ios/topics/aormfrest) · [anticoagulation manager](https://appshunter.io/ios/topics/anticoagulation-manager) · [managing dabigatran](https://appshunter.io/ios/topics/managing-dabigatran)

---

*Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-06-03.*